Institute of Cardiovascular and Me dical Sciences, University of Glasgow, Glasgow, UK.
School of Medicine, University of Glasgow, Glasgow, UK.
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgz248.
Maternal body mass index (BMI) is associated with increased birth weight but does not explain all the variance in fetal adiposity.
To assess the contribution of maternal body fat distribution to offspring birth weight and adiposity.
Longitudinal study throughout gestation and at delivery.
Women recruited at 12 weeks of gestation and followed up at 26 and 36 weeks. Cord blood was collected at delivery.
Pregnant women (n = 45) with BMI 18.0 to 46.3 kg/m2 and healthy pregnancy outcome.
Maternal first trimester abdominal subcutaneous and visceral adipose tissue thickness (SAT and VAT) was assessed by ultrasound.
Maternal body fat distribution, maternal and cord plasma glucose and lipid concentrations, placental weight, birth weight, and fetal adiposity assessed by cord blood leptin.
VAT was the only anthropometric measure independently associated with birth weight centile (r2 adjusted 15.8%, P = .002). BMI was associated with trimester 2 and trimesters 1 through 3 area under the curve (AUC) glucose and insulin resistance (Homeostatic Model Assessment). SAT alone predicted trimester 2 lipoprotein lipase (LPL) mass (a marker of adipocyte insulin sensitivity) (11.3%, P = .017). VAT was associated with fetal triglyceride (9.3%, P = .047). Placental weight was the only independent predictor of fetal adiposity (48%, P < .001). Maternal trimester 2 and AUC LPL were inversely associated with fetal adiposity (r = -0.69, P = .001 and r = -0.58, P = .006, respectively).
Maternal VAT provides additional information to BMI for prediction of birth weight. VAT may be a marker of reduced SAT expansion and increased availability of maternal fatty acids for placental transport.
母体体重指数(BMI)与出生体重增加有关,但并不能解释胎儿肥胖的所有差异。
评估母体体脂分布对后代出生体重和肥胖的贡献。
整个孕期和分娩时的纵向研究。
招募的孕妇在 12 周妊娠时,并在 26 周和 36 周时进行随访。分娩时采集脐血。
BMI 为 18.0 至 46.3kg/m2 且妊娠结局健康的孕妇。
通过超声评估孕妇孕早期腹部皮下和内脏脂肪组织厚度(SAT 和 VAT)。
母体体脂分布、母血和脐血血糖和血脂浓度、胎盘重量、出生体重和脐血瘦素评估的胎儿肥胖。
VAT 是唯一与出生体重百分位相关的人体测量指标(调整 r2 为 15.8%,P=0.002)。BMI 与妊娠 2 期和 1-3 期曲线下面积(AUC)血糖和胰岛素抵抗(稳态模型评估)相关。仅 SAT 可预测妊娠 2 期脂蛋白脂肪酶(LPL)质量(脂肪细胞胰岛素敏感性的标志物)(11.3%,P=0.017)。VAT 与胎儿甘油三酯相关(9.3%,P=0.047)。胎盘重量是胎儿肥胖的唯一独立预测因子(48%,P<0.001)。母体妊娠 2 期和 AUC LPL 与胎儿肥胖呈负相关(r=-0.69,P=0.001 和 r=-0.58,P=0.006)。
母体 VAT 为预测出生体重提供了 BMI 以外的信息。VAT 可能是 SAT 扩张减少和母体脂肪酸可供胎盘转运增加的标志物。